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Abstract
Background: Cutaneous amyloidosis has been classified into primary cutaneous amyloidosis (PCA, OMIM #105250),
secondary cutaneous amyloidosis and systemic cutaneous amyloidosis. PCA is the deposition of amyloid in
previously apparent normal skin without systemic involvement. Amyloidosis cutis dyschromica (ACD) is a rare
distinct type of PCA. Here, the unique clinical and histological findings of two Chinese female siblings with ACD
were described.
Cases presentations: Patient 1 was a 34-year-old female, presented with mildly pruritic, diffuse mottled
hyperpigmentation and hypopigmentation. The lesions involved all over the body since she was 10 years old.
There were a few itchy blisters appearing on her arms, lower legs and truck, especially on the sun-exposed areas in
summer. Some hypopigmented macules presented with slight atrophy. Patient 2 was 39-year-old, the elder sister
of patient 1. She had similar skin lesions since the same age as the former. The atrophy and blisters on the skin of
the patient with amyloidosis cutis dyschromica have not been described in previous literature. Histological
examinations of the skin biopsies taken from both patients revealed amyloid deposits in the whole papillary
dermis. Depending on the histological assessment, the two cases were diagnosed as amyloidosis cutis
dyschromica.
Conclusion: The two cases suggest that the atrophy and blisters may be the uncommon manifestations of
amyloidosis cutis dyschromica. It alerts clinicians to consider the possibility of ACD when meeting patients with
cutaneous dyschromia. Skin biopsy is essential and family consultation of genetic investigation is very important in
such cases.
Background
Cutaneous amyloidosis has been classified into primary
cutaneous amyloidosis (PCA, OMIM #105250), second-
ary cutaneous amyloidosis and systemic cutaneous amy-
loidosis. PCA is the deposition of amyloid in previously
apparent normal skin with no systemic involvement.
Amyloidosis cutis dyschromica (ACD) is a rare distinct
type of PCA. Here, the unique clinical and histological
findings of two Chinese female siblings with ACD were
described.
Cases presentations
Patient 1 was a 34-year-old female who presented with
mildly pruritic, diffuse mottled hyperpigmentation and
hypopigmentation. The lesions involved all over the
body since she was 10 years old. The hypopigmentated
macules were first noticed on her bilateral lower legs,
and had slowly progressed to involve the trunk, the
upper limbs, the thigh, the neck and the face with age
growing. She also noticed reticular hyperpigmentation
macules surrounding the spotty hypopigmentation.
There were a few itchy blisters which were sesame-like
or mung-bean-like in size appearing on her arms, lower
legs and truck, especially on the sun-exposed areas in
summer and the blisters were easy to burst. She did not
have the history of extensive sun exposure or any other
systemic or cutaneous disease before the onset of the
lesions.
On physical examination, she was well nourished and
her stature was 158 cm. The cutaneous examinations
revealed generalized, mottled, varying-sized hyperpig-
mented and hypopigmented macules ranging from 4 to
18 mm involving almost the entire body in a
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macules presented with slight atrophy. The skin lesions
were more pronounced on the lower legs (Figure 1A),
back and waist (Figure 1B, 1C), and the larger hypopig-
mented lesions were seen mainly on the lower legs.
Individual blisters which were negative Nikolsky sign
occurred on the upper arm (Figure 1D). The neck and
face were only mildly affected. There was no apparent
papular, erythema and telangiectasia. The dorsa of both
hands and feet were uninvolved. The hair, teeth, nails,
the mucosa of the mouth, palms, soles and vulva were
normal-looking. The hearing was normal. Systemic
examinations were unremarkable. The mental and
developmental milestones of the patients were normal.
Patient 2 was 39-year-old, the elder sister of patient 1.
Her stature was 149 cm. She had similar skin lesions
since the same age as patient 1. She presented with dif-
fuse hyperpigmentation and spotted hypopigmentation
especially on the lower legs and the waist. She had less
skin lesions than Patient 1, and did not show any pig-
mentation on the face or neck. Likewise, her systemic
examination was unremarkable.
They were born to nonconsanguineous parents. Their
mother had a small quantity of asymptomatic hypopig-
mented spots ranging from 2 to 4 mm in diameter on
bilateral lower legs and back which were not explored
further. Other family members have not similar
manifestation.
The results of skin biopsies taken from the lower legs
in both patients were similar. The pathological section
with haematoxylin and eosin stain revealed hyperkerato-
tic epidermis and papillary dermis fully filled with amor-
phous eosinophilic masses (Figure 2A). The Congo red
staining was positive to eosinophilic masses (Figure 2B),
which indicated a deposit of amyloid substance. If using
polarized light microscope, eosinophilic masses stained
with Congo red will show the characteristic of apple-
green birefringence. Additional staining with a marker
of HMB-45, in order to differentiate ACD from other
diseases with the characteristics of cutaneous dyschro-
mia, was negative (Figure 2C).
Other results of routine laboratory examinations
including routine blood test, biochemical profile, urine
protein excretion and chest X-ray, abdominal ultrasound
were normal in both patients.
Based on the clinical and pathological findings, the
diagnosis of amyloidosis cutis dyschromica (ACD) was
made for both patients. Topical tazarotene was pre-
scribed without obvious improvement over a 1-month
follow-up period.
Discussion
PCA includes the more common papular (lichen amyloi-
dosis) and macular types and nodular or tumefactive
form [1]. ACD is a more uncommon subtype of PCA
and was initially described by Morishima in 1970. This
disorder is characterized by the following features:
(i) dotted, reticular hyperpigmentation with hypopig-
mented spots without papulation almost all over the
body; (ii) no or little itchy sensation; (iii) onset before
puberty; and (iv) small foci of amyloid closely under the
epidermis [2,3]. Eng et al [4] first reported family survey
with ACD. Huang et al [5] and Choonhakarn et al [6]
collected four cases from two families and six cases
from three families respectively. Vijaikumar et al [7]
reported two siblings with ACD.
Our cases presented with reticular hyperpigmentation
with hypopigmented spots, which were generalized dis-
tribution and onset before puberty. The amyloid depos-
its were limited to the subepidermal region, without
other cutaneous and systemic involvement. All of these
were ranged ACD. Besides, in our patients, there are
some clinical features, dotty atrophy and blisters of skin,
that have not been described in previous literature
of ACD.
Figure 1 The clinical features of the patient 1 with ACD.T h e
hyperpigmented and hypopigmented macules on (A) lower legs,
(B) back and waist, (C) waist. (D) Individual blisters on upper arm.
Figure 2 The histological and immunohistochemical
examinations of the patient with ACD. (A) H&E staining indicated
hyperkeratotic epidermis and amorphous eosinophilic masses in the
papillary dermis. (original magnification × 40). (B) Congo red
staining indicated positive for eosinophilic masses. (original
magnification × 100). (C) The immunohistochemical examination
indicated negative for HMB-45. (original magnification × 100).
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characteristics of cutaneous dyschromia, including dys-
chromatosis universalis hereditaria, xeroderma pigmen-
tosum and poikloderma-like amyloidosis. It is necessary
to differentiate these diseases [3,8-10]. Amyloid deposits
can not be founded in the skin of the patients with dys-
chromatosis universalis hereditaria and xeroderma pig-
mentosum,. ACD and poikyloderma-like cutaneous
amyloidosis have similar clinical features. Poikyloderma-
like cutaneous amyloidosis is characterised by the pre-
sence of poikylodermic lesions, lichenoid papules and
blisters especially located on the limbs and appears in
adult life. It is associated with photosensitivity, low
height and a certain degree of palmo-plantar kerato-
derma. A few clinical features are overlapping between
ACD and poikloderma-like amyloidosis. In our patients,
there were dotty atrophy and vesicles of skin but no tel-
angiectasia and palmo-plantar keratoderma. Also their
statures were normal. Hence we do not know whether
the two type of PCA belong to the same kind of disease,
or there is a new subtype between the two types?
T h ee t i o l o g yo fP C Ar e m a i n su n k n o w n ,b u ti ti s
believed to be multifactorial. Our patients are two
female siblings and their mother has suspicious ACD.
Owing to the familial aggregation, it suggests that
genetic factors may play an important role in its patho-
genesis. Vijaikumar et al [7] proposed that genetic fac-
tors may lead to UVB sensitivity and DNA repair
defects. This repeated damage to the keratinocytes
results in the production of amyloid materials in the
skin [1]. However, genetic loci for familial PCA (FPCA)
have not been identified so far. The clinical features of
patients with PCA are varied. Whether genetic variabil-
ity determines the forms of expression of the disease
remains unknown.
Although the aetiology of PCA is not clear, some
researches still help to explore the skin disorder whether
linked to genetic pathogenesis. Lin’s team [11] implied
that a possible susceptibility locus for a subset of FPCA
might exist on chromosome 1q23. By further experi-
ments, an evidence of significant linkage to chromosome
5p13.1-q11.2 in a subset of FPCA was shown [12]. Lee
et al [13] elucidated that evidence was lack to support
for linkage of FPCA with the pericentromeric region of
chromosome 10. Arita et al [14] indicated missense
mutations of familial primary localized cutaneous amy-
loidosis (FPLCA) were located in the oncostatin M-spe-
cific receptor (OSMR) gene, which encodes oncostatin
M-specific receptor beta (OSMRb) –a component of the
oncostatin M (OSM) type II receptor and the interleu-
kin (IL)-31 receptor. Their OSMR data in individuals
with FPLCA represented the first human germline
mutations in this cytokine receptor complex. PCA can
be caused by mutations in two biologically associated
cytokine receptor genes located on chromosome 5 [15].
Novel IL31RA gene mutation and ancestral OSMR
mutant allele provide an explanation for the genetic
pathogenesis of PCA. Tanaka’s study [16] demonstrated
that most changes of gene expression revealed altera-
tions in epidermal differentiation and proliferation con-
sistent with lichenification. They also found a reduction
of several interfollicular keratinocyte stem cell markers
in FPLCA skin. Their results promoted the molecular
skin pathological progression on FPLCA.
The treating method of PCA is poor. topical corticos-
teroids, tretinoin, cryotherapy and carbon dioxide laser
have varying effects. Systemic acitretin have been
applied and suggest a good response [17].
Conclusion
Our cases suggest that the atrophy and blisters may be
the uncommon manifestations of amyloidosis cutis dys-
chromica. It alerts clinicians to consider the possibility
of ACD when meeting patients with cutaneous dyschro-
mia. Skin biopsy is essential and family consultation of
genetic investigation is very important in such cases.
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